š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a single-center, randomized, open-label, 3-period, 3-treatment mult...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00652431
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047501
Treatments Being Tested
The primary aim is to assess the effects of raising HDL cholesterol (the go...
Status
Completed
Location
Clinical Trial Service Unit, University of Oxford
Start Date
2007-01
Trial ID
NCT00461630
Treatments Being Tested
To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in ...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00271817
Treatments Being Tested
AMR101 (icosapent ethyl \[ethyl-EPA\]) is a highly purified ethyl ester of ...
Status
Completed
Location
Amarin Investigational Site
Start Date
2011-11
Trial ID
NCT01492361
Treatments Being Tested
The purpose of this study is to investigate the added benefits of increased...
Status
Completed
Location
Johns Hopkins Unversity School of Medicine
Start Date
2003-09
Trial ID
NCT00127218
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047683
Treatments Being Tested